Blackstone's debut investment in the Indian healthcare sector was the acquisition of a significant stake in QCIL earlier this year, valued at USD 800 million (₹6,600 crore)
Read MoreIndustry-wide reimbursements form 40 per cent of overall health claims, Plum's user-centric approach reduces the reimbursement claim process time from 7 days to just an hour
Read MoreBlue Jet Healthcare's Initial Public Offering (IPO) with a total worth of Rs 840.27 crore is set to begin accepting subscriptions on October 25
Read MoreThe purchase involves the acquisition of Telavant from Roivant Holdings and Pfizer Inc.
Read MoreManipal HealthMap bought an 84 per cent stake in Medcis Pathlabs in April 2022 by paying Rs 100 crore in an all-cash transaction.
Read MoreThe funds will be primarily utilised for marketing and development of new products. This investment will help the company in building its product portfolio and enhancing its R&D prowess.
Read MoreVenus Remedies secured authorisation for six oncology products in the Philippines, bringing their global total to 525 approvals across 76 countries
Read MoreGlobal Data has forecasted a compound annual growth rate (CAGR) of 5.2 per cent from USD31.9 billion in 2022 to USD53 billion in 2032 for the heart failure market.
Read More